Annals of Laboratory Medicine

Annals of Laboratory Medicine is a peer-reviewed bimonthly journal covering laboratory medicine and clinical chemistry, founded in 1985 in South Korea and published by Seoul National University, with a 2025 Journal Impact Factor of 4.4《实验医学年报》（Annals of Laboratory Medicine）是韩国首尔大学于 1985 年创办的同行评审双月刊，覆盖实验医学与临床化学，2025 年影响因子为 4.4。

Scope

• Annals of Laboratory Medicine publishes original research on clinical chemistry, haematology, immunology and molecular diagnostics该刊发表临床化学、血液学、免疫学与分子诊断方面的原创研究。
• Topics include clinical chemistry, immunoassay development and laboratory automation主题涵盖临床化学、免疫分析开发与实验室自动化。
• Haematology, coagulation and blood transfusion medicine are within scope血液学、凝血与输血医学亦在收稿范围之内。
• Microbiology, virology and infectious disease diagnostics are covered微生物学、病毒学与传染病诊断亦在覆盖范围。
• Molecular diagnostics, next-generation sequencing and clinical genomics are highlighted分子诊断、二代测序与临床基因组学是重点方向。
• Laboratory quality management and accreditation are within scope实验室质量管理与认证亦在收稿范围之内。
• All articles are published gold open access under a Creative Commons CC BY-NC licence所有文章以（Creative Commons CC BY-NC）许可作为金色开放获取发布。
• Authors benefit from open-access visibility and rapid peer review作者受益于开放获取可见度与快速同行评审。
• Submissions are subject to peer review under the journal's editorial policies稿件按该刊编辑政策进行同行评审。

History

• Annals of Laboratory Medicine was founded in 1985 as the Korean Journal of Clinical Pathology by the Korean Society for Laboratory Medicine《实验医学年报》于 1985 年由韩国实验医学学会以《Korean Journal of Clinical Pathology》创办。
• It has been continuously published with the Korean Society for Laboratory Medicine as its sponsor该刊以韩国实验医学学会为赞助方持续出版。
• In 2012, the journal was renamed to Annals of Laboratory Medicine2012 年该刊更名为《Annals of Laboratory Medicine》。
• The journal is published bimonthly with electronic ISSN 2234-3814 and registered print ISSN 2234-3806该刊以双月刊出版，电子 ISSN 2234-3814，印刷版 ISSN 2234-3806。
• It has been indexed in SCIE since 2014 and has become a leading venue for Asian laboratory medicine research该刊自 2014 年起被（SCIE）收录，并成为亚洲实验医学研究的领军期刊。
• Throughout its history, the journal has documented the development of laboratory medicine in Korea and globally其整个历史上记录了韩国及全球实验医学的发展。
• Its 2025 Journal Impact Factor is 4.4, with 3.9 in 2024 and 4.941 in 2022 (peak)2025 年影响因子为 4.4，2024 年为 3.9，2022 年峰值为 4.941。
• Editorial office is at Seoul National University Hospital in Seoul, South Korea编辑部位于韩国首尔的首尔大学医院。
• The journal has hosted themed issues on molecular diagnostics and laboratory quality management该刊曾主办分子诊断与实验室质量管理专题专辑。
• Papers are subject to peer review under Seoul National University editorial policies稿件按首尔大学编辑政策进行同行评审。
• Editorial board members include leading clinical chemists and laboratory medicine specialists from Korea and around the world编委包括来自韩国及全球的领军临床化学家与实验医学专家。
• The journal has expanded its international editorial board over the past decade该刊过去十年间不断扩展其国际编委会。
• Editorial decisions emphasise scientific rigour and clinical relevance编辑决定强调科学严谨性与临床相关性。
• The journal is committed to open access publishing and rapid dissemination of laboratory medicine research期刊致力于开放获取出版与实验医学研究的快速传播。
• Editorial leadership has been anchored at Seoul National University with international committee input编辑领导层挂靠首尔大学，并有国际委员会参与。
• The journal collaborates with international laboratory medicine societies期刊与国际实验医学学会合作。
• The journal supports emerging topics such as liquid biopsy and clinical genome sequencing期刊支持液体活检与临床基因组测序等新兴话题。
• Special issues bring together themed collections on laboratory medicine topics期刊通过专题专辑聚焦实验医学议题。
• The journal maintains high visibility through indexing in MEDLINE and Scopus该刊通过（MEDLINE）与（Scopus）收录保持高可见度。

Editors

• Hyun-Ki Kim of Seoul National University College of Medicine is the Editor-in-Chief现任主编为首尔大学医学院的（Hyun-Ki Kim）。
• He has extensive clinical chemistry expertise and has served the journal in various editorial capacities他具有丰富的临床化学专长，并在该刊担任多种编辑职务。
• Section editors handle submissions across clinical chemistry, haematology and molecular diagnostics板块编辑分管临床化学、血液学与分子诊断等方向的稿件。
• The editorial board includes leading laboratory medicine experts from Korea and internationally编委包括来自韩国及国际的领军实验医学专家。
• Manuscripts are subject to peer review under the journal's editorial policies稿件按该刊编辑政策进行同行评审。
• Editorial decisions emphasise methodological rigour and clinical impact编辑决定强调方法严谨性与临床影响。
• The journal supports rapid communication of laboratory medicine research期刊支持实验医学研究的快速传播。
• Editorial board members are drawn from major hospital laboratories in Korea and Asia编委来自韩国与亚洲的主要医院实验室。
• The journal maintains close links with the Korean Society for Laboratory Medicine期刊与韩国实验医学学会保持密切联系。
• Editorial decisions take into account both clinical relevance and innovation编辑决定兼顾临床相关性与创新。